Free Trial
LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

Advanced Oncotherapy logo
GBX 1.75 -0.18 (-9.09%)
(As of 08/30/2023)

About Advanced Oncotherapy Stock (LON:AVO)

Key Stats

Today's Range
1.75
1.75
50-Day Range
1.75
1.75
52-Week Range
1.75
25.75
Volume
200,000 shs
Average Volume
1.27 million shs
Market Capitalization
£9.49 million
P/E Ratio
N/A
Dividend Yield
5.49%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Stock News Headlines

AVO.L Regulatory News
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
Advanced Oncotherapy Share Chat
Advanced Oncotherapy PLC AVO
See More Headlines

AVO Stock Analysis - Frequently Asked Questions

Advanced Oncotherapy's stock was trading at GBX 1.75 on January 1st, 2024. Since then, AVO stock has increased by 0.0% and is now trading at GBX 1.75.
View the best growth stocks for 2024 here
.

Advanced Oncotherapy plc (LON:AVO) posted its quarterly earnings data on Monday, June, 29th. The company reported ($9.83) earnings per share for the quarter, missing the consensus estimate of ($8.90) by $0.93.

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Academy Sports and Outdoors (ASO), Renishaw (RSW), Tullow Oil (TLW), BMR Group (BMR), Lancashire (LRE) and Sirius Minerals (SXX).

Company Calendar

Last Earnings
6/29/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
Agriculture
CIK
N/A
Fax
N/A
Employees
3,900
Year Founded
N/A

Profitability

Net Income
£-32,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 0.05 per share
Book Value
GBX 14 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.49 million
Optionable
Not Optionable
Beta
0.06
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (LON:AVO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners